Streetbeat News

Equity Actions

RAY

Trading halt status was updated at 10:35:00 AM ET for an IPO security, which has now been released for quotation.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 2:35 pm

RAY

Raytech Holding Limited (RAY) has priced its IPO at $4 per share, raising $6 million. The shares are now trading on the Nasdaq Capital Market under the ticker symbol 'RAY'. The company specializes in personal care electrical appliances.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 2:03 pm

AEMD

Aethlon Medical has announced the pricing of a public offering for 8.1 million shares of common stock, along with Class A and B warrants, at $0.58 per share.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 1:19 pm

AMC

GME

AMC Entertainment Holdings Inc (NYSE:AMC) shares are trading lower on Wednesday after announcing agreements to issue stock in exchange for notes and completing an equity offering. The stock had previously rallied alongside GameStop Corp (NYSE:GME) due to renewed interest from Keith Gill, known as 'Roaring Kitty'.

Portfolio Pulse from Adam Eckert

May 15, 2024 | 1:05 pm

AMC

AMC Entertainment shares are trading lower after a recent rally. The company announced agreements to issue stock in exchange for notes.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 1:04 pm

AQMS

Aqua Metals has announced a $7 million public offering of 17.5 million shares of common stock and non-redeemable warrants.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 1:00 pm

CTHR

Charles & Colvard has announced a 1-for-10 reverse stock split effective May 17, 2024, to comply with Nasdaq's $1.00 minimum bid price requirement. Split-adjusted trading will begin on the same day.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 12:56 pm

DT

Dynatrace shares are trading higher after the company reported better-than-expected Q4 financial results and approved a share buyback program of up to $500 million.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 12:51 pm

YTEN

Yield10 Bioscience has announced its decision to delist from Nasdaq. This move could have significant implications for the company's stock and its investors.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 12:31 pm

VRPX

Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) announced the pricing of a public offering of 1,666,667 shares of common stock and warrants, aiming to raise approximately $2.25 million. The offering includes Series A-1 and A-2 common warrants, both exercisable immediately at $1.35 per share.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 12:22 pm